Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

[1] Simabuco FM(2020)Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses Genet Mol Biol. 44 e20200212-1242

[2] Tamura RE(2020)Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy Metabolism. 108 154254-550

[3] Pavan ICB(2020)Admission hyperglycemia and radiological findings of SARS-COv2 in patients with and without diabetes Diabetes Res Clin Pract 164 108185-47 e3

[4] Morale MG(2020)Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory Diabetes Res Clin Pract. 163 108186-1059

[5] Ventura AM(2020)Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention JAMA 323 1239-2294

[6] Means C(2020)Impact of diabetes in patients diagnosed with COVID-19 Front Immunol. 11 576818-22

[7] Iacobellis G(2020)Practical recommendations for the management of diabetes in patients with COVID-19 Lancet Diabetes Endocrinol 8 546-1515

[8] Penaherrera CA(2020)Novel molecular evidence related to COVID-19 in patients with diabetes mellitus J Clin Med. 9 3962-1407

[9] Bermudez LE(2020)Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing Type 2 diabetes Cell Metab. 32 537-157

[10] Bernal Mizrachi E(2020)Risk of metformin in patients with Type 2 diabetes with COVID-19: a preliminary retrospective report Clin Transl Sci 13 1055-e41

[1] Simabuco FM(2020)Molecular mechanisms and pharmacological interventions in the replication cycle of human coronaviruses Genet Mol Biol. 44 e20200212-1242

[2] Tamura RE(2020)Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy Metabolism. 108 154254-550

[3] Pavan ICB(2020)Admission hyperglycemia and radiological findings of SARS-COv2 in patients with and without diabetes Diabetes Res Clin Pract 164 108185-47 e3

[4] Morale MG(2020)Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory Diabetes Res Clin Pract. 163 108186-1059

[5] Ventura AM(2020)Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the chinese center for disease control and prevention JAMA 323 1239-2294

[6] Means C(2020)Impact of diabetes in patients diagnosed with COVID-19 Front Immunol. 11 576818-22

[7] Iacobellis G(2020)Practical recommendations for the management of diabetes in patients with COVID-19 Lancet Diabetes Endocrinol 8 546-1515

[8] Penaherrera CA(2020)Novel molecular evidence related to COVID-19 in patients with diabetes mellitus J Clin Med. 9 3962-1407

[9] Bermudez LE(2020)Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing Type 2 diabetes Cell Metab. 32 537-157

[10] Bernal Mizrachi E(2020)Risk of metformin in patients with Type 2 diabetes with COVID-19: a preliminary retrospective report Clin Transl Sci 13 1055-e41